- Home
- FGI vs ADXN Comparison
FGI vs ADXN Comparison
Compare FGI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGI
- ADXN
- Stock Information
- Founded
- FGI 1987
- ADXN 2002
- Country
- FGI United States
- ADXN Switzerland
- Employees
- FGI N/A
- ADXN N/A
- Industry
- FGI Industrial Specialties
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- FGI Industrials
- ADXN Health Care
- Exchange
- FGI Nasdaq
- ADXN Nasdaq
- Market Cap
- FGI 7.2M
- ADXN 7.5M
- IPO Year
- FGI 2022
- ADXN N/A
- Fundamental
- Price
- FGI $0.51
- ADXN $7.60
- Analyst Decision
- FGI
- ADXN Strong Buy
- Analyst Count
- FGI 0
- ADXN 1
- Target Price
- FGI N/A
- ADXN $30.00
- AVG Volume (30 Days)
- FGI 84.8K
- ADXN 8.7K
- Earning Date
- FGI 05-07-2025
- ADXN 06-05-2025
- Dividend Yield
- FGI N/A
- ADXN N/A
- EPS Growth
- FGI N/A
- ADXN N/A
- EPS
- FGI N/A
- ADXN 0.06
- Revenue
- FGI $131,818,073.00
- ADXN $701,260.00
- Revenue This Year
- FGI $8.04
- ADXN N/A
- Revenue Next Year
- FGI $6.41
- ADXN N/A
- P/E Ratio
- FGI N/A
- ADXN $0.99
- Revenue Growth
- FGI 12.43
- ADXN N/A
- 52 Week Low
- FGI $0.46
- ADXN $6.51
- 52 Week High
- FGI $1.36
- ADXN $17.05
- Technical
- Relative Strength Index (RSI)
- FGI 34.67
- ADXN 52.85
- Support Level
- FGI $0.48
- ADXN $6.75
- Resistance Level
- FGI $0.64
- ADXN $8.20
- Average True Range (ATR)
- FGI 0.08
- ADXN 0.46
- MACD
- FGI 0.00
- ADXN 0.06
- Stochastic Oscillator
- FGI 18.35
- ADXN 64.50
About FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.